Not Tagged
Castle Biosciences
[]
late-breaking data presented at the 2023 aad annual meeting demonstrates improved accuracy of decisiondx -scc in predicting metastatic risk over traditional staging systems in independent, multi-center cohort study - -
MD MSC CPDS https://t.co/YL6HxBReRh https://t.co/kePCRsN4Gw  https://t.co/t7oxnCVsEI  #cardiology  #AI #informatics #healthcare #innovation #Data